Action | 21 Jul 2026 02:08:50 ET │ 10 pages Telix Pharmaceuticals Ltd ADR (TLX.O) Removing Upside 30-Day Catalyst Watch We are closing our catalyst watch on Telix following an ahead of VA consensus 2Q sales print, although the shares were little moved. | Buy / High Risk | | --- | | Price (20 Jul 26 16:00) | US$10.51 | | --- | --- | | Target price | US$22.00 | | Expected share price return | 109.3% | | Expected dividend yield | 0.0% | | Expected total return | 109.3% | | Market Cap | US$3,571M | Laura Sutcli ...